Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.

@article{DezMartn2009ComparableSB,
  title={Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.},
  author={Jos{\'e} Lu{\'i}s D{\'i}ez-Mart{\'i}n and Pascual Balsalobre and Alessandro Re and Mariagrazia Michieli and Jos{\'e} Mar{\'i}a Ribera and Carmen Canals and E. G{\'o}mez Conde and Anne Rosselet and Ian Gabriel and Rosario Varela and Bernardino Allione and Kate Cwynarski and Philippe Genet and Ildefonso Espigado and Pierre Biron and Norbert Schmitz and Anne E Hunter and Augustin Ferrant and Gaelle Guillerm and Mark Hentrich and M. {\`A}ngels Jurado and Pascual Fern{\'a}ndez and David Serrano and Giuseppe Rossi and Anna Sureda},
  journal={Blood},
  year={2009},
  volume={113 23},
  pages={6011-4}
}
Autologous stem cell transplantation (ASCT) has been successfully used in HIV-related lymphoma (HIV-Ly) patients on highly active antiretroviral therapy. We report the first comparative analysis between HIV-Ly and a matched cohort of HIV(-) lymphoma patients. This retrospective European Group for Blood and Marrow Transplantation study included 53 patients (66% non-Hodgkin and 34% Hodgkin lymphoma) within each cohort. Both groups were comparable except for the higher proportion of males, mixed… CONTINUE READING